Aug 02,2019

Hello Heart Secures $12M in Funding for Mobile Health Solution

Hello Heart recently completed a $12M Series B led by Khosla Ventures, a top-tier firm who’s active in AI and health investments. With this funding, Hello Heart is plans to take its operations to the next level and improve upon their mobile health solution.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 11,2018

Livongo gets $105 million, signs deal with insurer Cambia Health Solutions

Digital chronic disease management company Livongo has raised $105 million in new Series E funding. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions. Livongo will work with Cambia to roll out its existing diabetes management and hypertension management offerings to Cambia members, and to work with Cambia to create coaching and monitoring platforms for additional chronic conditions.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Jul 23,2018

Sanofi Ventures Leads $17 Million Financing of Click Therapeutics

Click Therapeutics announces a $17 million financing round led by Sanofi Ventures. Click will use this financing to continue advancing its proprietary platform and pipeline of prescription digital therapeutics to treat a wide range of diseases. Recent notes were converted to equity as part of the financing.

FUNDING FUNDING ROUND

#mobile app

#pdt

#software

View Analyst & Ambassador Comments
Go to original news
Aug 09,2018

Digital therapeutics maker Akili adds extra $13M to earlier $55M funding round

Boston-based digital therapeutics company Akili Interactive Labs announced this morning that it has added an extra $13 million to its previously announced Series C financing. Together, this brings the company’s 2018 funding to $68 million, and its total backing to just over $140 million. The additional investment from CLSA, Omidyar Technology Ventures, Digital Garage Group, and Fearless Ventures will be used to support development and deployment Akili’s digital therapeutics, one of which is currently under review by the FDA.

FUNDING SERIES C

#pdt

View Analyst & Ambassador Comments
Go to original news
Aug 28,2018

Renovia raises $32.3M for app-connected pelvic floor therapy system

Last week Renovia, maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy, announced the closure of a $32.3 million Series B equity round and an additional $10 million of debt financing. The round was led by Perceptive Advisors and Ascension Ventures, with additional participation from Longwood Fund, Inova Strategic Investments, Cormorant Asset Management, OSF Ventures, and Western Technology Investment. According to a statement, the new backing will be put toward clinical trials, corporate development, development of the company’s product pipeline, and supporting upcoming commercial launches.

FUNDING SERIES B

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 02,2018

Pear Therapeutics Completes $50 Million Series B Financing

PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50 million Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative. PEAR is the first company to receive U.S. Food and Drug Administration (FDA) clearance for a prescription digital therapeutic with claims to improve clinical outcomes in a disease. The financing will allow the company to commercialize its lead programs and further develop its pipeline and platform.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 28,2018

Japan’s medtech startup CureApp gets $14M to help reduce lifestyle diseases globally

Japan’s digital health startup CureApp announced on Monday that it has fundraised 1.5 billion yen (about $14 million) in the latest round. This follows their previous $3.4 million funding. In addition to existing investors BNV and KII, participating investors in this round are Itochu Corporation (TSE:8001), Itochu Technology Ventures, Cyberdine (TSE:7779), Dai-ichi Life (TSE:8750), Mitsubishi UFJ Capital, Iwagin Jigyo Souzou Capital, Saison Ventures, Chibagin Capital, and Mizuho Capital.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 09,2018

Finnish patient monitoring platform closes $5.4M funding round

Helsinki, Finland-based Kaiku Health, which offers digital patient monitoring and patient-reported outcome services designed for several medical specialties, has announced $5.4 million (4.4 million euros) in Series A financing. The round was led by Debiopharm Innovation Fund SA and Tesi, with additional participation from new investor Prodeko Ventures and returning supporters Reaktor Ventures, Metsola Ventures, and Athensmed.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 16,2018

Sword Health lands $4.6M for digital physical therapy

Digital physiotherapy company Sword Health has brought in $4.6 million in a seed funding round led by Green Innovation, Vesalius Biocapital III, and other unnamed US and European investors. Sword Phoenix is a platform that uses artificial intelligence to understand each patient's needs, and provide responsive feedback during treatment and remote guidance from clinical teams, according to its webpage.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
May 09,2018

Akili collects $55M to support pipeline development, regulatory submission

This morning, Boston-based Akili Interactive Labs announced the closure of a $55 million Series C funding round. The investment was led by Temasek, with participation from Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Fund, and Brooklands Capital Strategies. According to the company, this new funding will be used to support development, regulatory submission, and commercialization of Akili’s pipeline of digital therapy candidates. This includes AKL-T01, a video game specifically designed to treat pediatric ADHD that the company will soon be filing for FDA clearance.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING